Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−26.36 USD
−24.21 M USD
0.00 USD
1.94 M
About Aptose Biosciences. Inc.
Sector
Industry
CEO
William G. Rice
Website
Headquarters
Toronto
Founded
1986
FIGI
BBG000F3W6V3
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of APTOF is 1.66 USD — it has increased by 3.23% in the past 24 hours. Watch Aptose Biosciences. Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Aptose Biosciences. Inc. stocks are traded under the ticker APTOF.
APTOF stock has risen by 18.57% compared to the previous week, the month change is a 12.16% rise, over the last year Aptose Biosciences. Inc. has showed a −99.74% decrease.
APTOF reached its all-time high on Mar 6, 2000 with the price of 446,691,105.00 USD, and its all-time low was 0.64 USD and was reached on Jun 18, 2025. View more price dynamics on APTOF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
APTOF stock is 3.23% volatile and has beta coefficient of −2.65. Track Aptose Biosciences. Inc. stock price on the chart and check out the list of the most volatile stocks — is Aptose Biosciences. Inc. there?
Today Aptose Biosciences. Inc. has the market capitalization of 4.12 M, it has decreased by −0.67% over the last week.
Yes, you can track Aptose Biosciences. Inc. financials in yearly and quarterly reports right on TradingView.
Aptose Biosciences. Inc. is going to release the next earnings report on Aug 7, 2025. Keep track of upcoming events with our Earnings Calendar.
APTOF earnings for the last quarter are −2.61 USD per share, whereas the estimation was −2.67 USD resulting in a 2.25% surprise. The estimated earnings for the next quarter are −2.74 USD per share. See more details about Aptose Biosciences. Inc. earnings.
APTOF net income for the last quarter is −5.53 M USD, while the quarter before that showed −1.54 M USD of net income which accounts for −258.78% change. Track more Aptose Biosciences. Inc. financial stats to get the full picture.
No, APTOF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 20, 2025, the company has 13 employees. See our rating of the largest employees — is Aptose Biosciences. Inc. on this list?
Like other stocks, APTOF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aptose Biosciences. Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aptose Biosciences. Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aptose Biosciences. Inc. stock shows the sell signal. See more of Aptose Biosciences. Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.